FTXH.US First Trust Nasdaq Pharmaceuticals ETF
- Total assets
- 1.20B
- Expense ratio
- 0.57%
- Dividend yield
- 0.67%
- 1-year return
- +41.34%
- Holdings
- 50
- Since
- 2016
Fund data as reported by the issuer, updated Nov 14, 2026. Total assets are in the fund's base currency.
What does FTXH.US invest in?
- Mostly US stocks (94.6%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (99.6%)
- Top 3 holdings: 23.0% of the fund
Asset allocation
- US stocks 94.6%
- Non-US stocks 0.6%
- Cash 0.0%
Top holdings
- Eli Lilly and Company 7.97%
- AbbVie Inc 7.89%
- Johnson & Johnson 7.09%
- Pfizer Inc 6.90%
- Merck & Company Inc 6.69%
First Trust Nasdaq Pharmaceuticals ETF performance
Sharpe ratio 1.37- This year
- +35.18%
- 1 year
- +41.34%
- 3 years
- +23.17%
- 5 years
- +11.44%
Volatility 15.0% over 1 year and 14.5% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
FTXH.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About First Trust Nasdaq Pharmaceuticals ETF
The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.
Full fund profileFirst Trust Nasdaq Pharmaceuticals ETF top holdings
56.3% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Eli Lilly and Company LLY.US | Healthcare | United States | 7.97% |
| AbbVie Inc ABBV.US | Healthcare | United States | 7.89% |
| Johnson & Johnson JNJ.US | Healthcare | United States | 7.09% |
| Pfizer Inc PFE.US | Healthcare | United States | 6.90% |
| Merck & Company Inc MRK.US | Healthcare | United States | 6.69% |
| Regeneron Pharmaceuticals Inc REGN.US | Healthcare | United States | 4.17% |
| Viatris Inc VTRS.US | Healthcare | United States | 4.05% |
| Biogen Inc BIIB.US | Healthcare | United States | 3.89% |
| Amgen Inc AMGN.US | Healthcare | United States | 3.83% |
| Gilead Sciences Inc GILD.US | Healthcare | United States | 3.79% |
The 10 largest of 50 holdings.
FTXH.US sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
FTXH.US regional exposure
- North America99.6%
- United Kingdom0.6%
Share of the stocks in the fund.
Company size
Average market cap 86.5B- Mega cap8.0%
- Big cap45.1%
- Medium cap27.3%
- Small cap15.4%
- Micro cap1.6%
First Trust Nasdaq Pharmaceuticals ETF fund profile
- Fund name
- First Trust Nasdaq Pharmaceuticals ETF
- Ticker
- FTXH.US
- Exchange
- USA Stocks
- Issuer
- First Trust
- Index tracked
- -
- Category
- Healthcare Equity
- Domicile
- United States
- Inception date
- Sep 20, 2016
- Trading currency
- USD
- Expense ratio
- 0.57%
- Annual turnover
- 0.7%
About First Trust Nasdaq Pharmaceuticals ETF
The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.